| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-06 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-06 |